Ticker brief
CRVS CORVUS PHARMACEUTICALS INC
Consumer, Non-cyclical · Pharmaceuticals
last close
$10.53
1 day
-1.1%
14 days
+0.1%
mkt cap
$1.3B
signals 14d
16
authors 14d
4
crowd 14d
+0.37
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 66% cheap · 1 pctile own 1y | IV/HV 1.05× (as of 2026-08-18) |
| Skew — 25Δ RR 30d | +0.050 97 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +1.27 elevated | 5-session Δ -0.60 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2026-04-24 (z=3.0) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-06 → 2026-10-16 · now +0.00 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @OptionsFlowBoss | C | · | 9 | +0.22 |
| @semodough | C | -1.06 | 5 | +0.39 |
| @TheNewMoney_app | C | · | 1 | +0.20 |
| @OpenOutcrier | C | · | 1 | -0.30 |
Recent signals16of 16 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @OptionsFlowBoss | +0.00 | Shares CRVS open-interest changes without a textual directional interpretation. | +10.6% | tweet ↗ |
| 2026-10-15 | @OpenOutcrier | -0.30 | Recaps unusual put activity across multiple securities and expiries. | +6.9% | tweet ↗ |
| 2026-10-15 | @OptionsFlowBoss | +0.50 | Reports a CRVS put seller and flags tomorrow's open interest, implying bullish positioning. | +6.9% | tweet ↗ |
| 2026-10-15 | @OptionsFlowBoss | +0.50 | Reports a whale put seller in CRVS alongside open-interest changes. | +6.9% | tweet ↗ |
| 2026-10-14 | @semodough | +0.10 | Relays dermatologist efficacy and monitoring thresholds for oral treatments versus Dupixent. | +12.3% | tweet ↗ |
| 2026-10-14 | @TheNewMoney_app | +0.20 | Reports a large CRVS call purchase with strike, premium and expiry. | +12.3% | tweet ↗ |
| 2026-10-14 | @OptionsFlowBoss | +0.50 | Reports a detected whale put seller in CRVS, implying bullish positioning. | +12.3% | tweet ↗ |
| 2026-10-13 | @semodough | +0.60 | Projects blockbuster revenue for oral drugs combining biologic efficacy with placebo-like safety. | +11.9% | tweet ↗ |
| 2026-10-12 | @OptionsFlowBoss | +0.00 | References CRVS open-interest changes shown in media. | +4.8% | tweet ↗ |
| 2026-10-11 | @OptionsFlowBoss | +0.00 | Flags CRVS open interest for review tomorrow. | +0.1% | tweet ↗ |
| 2026-10-11 | @OptionsFlowBoss | +0.00 | Shares CRVS gamma heat zones without visible levels or direction. | +0.1% | tweet ↗ |
| 2026-10-09 | @semodough | +0.15 | Questions KYMR's valuation at 10x CRVS, 7x NKTR and 1.5x ABVX. | +0.1% | tweet ↗ |
| 2026-10-07 | @OptionsFlowBoss | +0.50 | Reports bullish call-spread positioning in CRVS. | +1.2% | tweet ↗ |
| 2026-10-06 | @OptionsFlowBoss | +0.00 | Directs readers to check CRVS open interest tomorrow without stating direction. | -0.3% | tweet ↗ |
| 2026-10-06 | @semodough | +0.55 | Expects China data to validate the drug class and support a return toward $15–18. | -0.3% | tweet ↗ |
| 2026-10-06 | @semodough | +0.55 | Cites Cantor's year-end catalyst with a modeled +50% upside and -10% downside. | -0.3% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.